SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Friday 6 November 2026
News from the 24 hours to Friday morning, 6 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on Smith & Nephew reducing its 2026 profit forecast although third-quarter revenue grew 3.4%, with the shares dropping and talks with J&J finishing. UBS raising its price target and keeping a neutral rating gave only a small counterweight.
What drove it
- profit forecast cut
- Q3 results
- J&J talks ended
Around this day
4 stories · 5 headlines · strongest first
Pharma and healthcare on 6 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Smith & Nephew lowers 2026 guidance and ends talks with J&J −4.42 headlines today · 22 in all, since 9 October · Coverage recounts a lower 2026 profit forecast alongside 3.4% third-quarter revenue growth, and the termination of talks with J&J. | ||
| −9.7 | Shares dropped on guidance cut; talks with J&J ended, leaving orthopaedics options open. | |
| −8.7 | Lowered full-year profit guidance outweighs modest third-quarter sales growth. | |
| UBS increases its Smith & Nephew price target and holds Neutral view +3.01 headline today · UBS lifted its price target while keeping a Neutral rating. | ||
| +3.0 | Broker lifted its price target but stayed neutral on the shares. | |
| Smith & Nephew robotics and cash flow examined −1.31 headline today · A piece looks at the company's robotics and cash flow. | ||
| −1.3 | Robotics investment puts pressure on cash generation, with outcome still uncertain. | |
| Smith & Nephew outlook commentary 0.01 headline today · A commentary asks what could change views on the shares. | ||
| 0.0 | Generic analysis piece on factors that might shift outlook; no clear direction. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.